Although elevated endogenous FGF21 fails to induce the desired physiologic effects of lipid and glucose homeostasis during obesity, pharmacological administration of FGF21 appears to exert beneficial actions to improve metabolic parameters in mice [6, 7]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.